Fort Myers cancer lab firm wins federal patent lawsuit

Fort Myers-based cancer-focused genetic testing services firm NeoGenomics has won a summary judgement in a patent infringement case with a Texas competitor. 

Austin-based Natera sued NeoGenomics in federal court in North Carolina. Natera claimed in court documents that NeoGenomics had infringed on two of its patented products that provide early detection of cancer relapse. A federal judge had issued an injunction in the case against NeoGenomics in 2023. 

The ruling handed down Friday dismisses Natera’s claims against NeoGenomics “with prejudice and enters declaratory judgment of invalidity of both of Natera’s asserted patents,” according to a statement from the Fort Myers lab company.